[1] Chia F L, Leong K P. Severe cutaneous adverse reactions to drugs [J]. Curr Opin Allergy Clin Immunol, 2007, 7 (4): 304-309.
[2] Odom R B. 安德鲁斯皮肤病学[M]. 9版. 北京: 科学出版社, 2001: 132-135.
[3] Braun-Falco O, Plewig G, Burgdorf W H C, et al. Braun-Falco's Dermatology[M]. 3rd Edition. Berlin: Springer-Verlag Berlin and Heidelberg GmbH & Co. K. 2008: 473-483.
[4] Patel P P, Gandhi A M, Desai C K, et al. An analysis of drug induced Stevens-Johnson syndrome [J]. Indian J Med Res,2012, 136(6): 1051-1053.
[5] Angelopoulou M A, Poziopoulos C, Boussiotis V A,et al. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response[J]. Leuk Lymphoma, 1996,21(3-4):321-324.
[6] Klasa R J, Meyer R M, Shustik C, et al. Randomized phase Ⅲ study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin’s lymphoma previously treated with an alkylating agent or alkylator-containing regimen[J]. J Clin Oncol,2002,20(24):4649-4654.
[7] 邓文郁, 江 丽, 李 茂. Stevens-Johnson综合征误诊为白塞氏病1例[J]. 中华风湿病杂志, 2006,10(2):68.
[8] 刘 洁, 曾跃平, 何春霞,等. 糖皮质激素联合人免疫球蛋白治疗Stevens-Johnson综合征和中毒性表皮松解症[J]. 协和医学杂志, 2012, 3(4): 381-385.